Grijalvo Santiago, Puras Gustavo, Zárate Jon, Sainz-Ramos Myriam, Qtaish Nuseibah A L, López Tania, Mashal Mohamed, Attia Noha, Díaz David, Pons Ramon, Fernández Eduardo, Pedraz José Luis, Eritja Ramon
Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, E-08034 Barcelona, Spain.
Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), E-08034 Barcelona, E-01006 Vitoria-Gasteiz and E-03202 Elche, Spain.
Pharmaceutics. 2019 Jan 22;11(2):50. doi: 10.3390/pharmaceutics11020050.
Cationic niosomes have become important non-viral vehicles for transporting a good number of small drug molecules and macromolecules. Growing interest shown by these colloidal nanoparticles in therapy is determined by their structural similarities to liposomes. Cationic niosomes are usually obtained from the self-assembly of non-ionic surfactant molecules. This process can be governed not only by the nature of such surfactants but also by others factors like the presence of additives, formulation preparation and properties of the encapsulated hydrophobic or hydrophilic molecules. This review is aimed at providing recent information for using cationic niosomes for gene delivery purposes with particular emphasis on improving the transportation of antisense oligonucleotides (ASOs), small interference RNAs (siRNAs), aptamers and plasmids (pDNA).
阳离子非离子型脂质体已成为用于运输大量小分子药物和大分子的重要非病毒载体。这些胶体纳米颗粒在治疗中日益受到关注,这取决于它们与脂质体的结构相似性。阳离子非离子型脂质体通常由非离子表面活性剂分子自组装而成。这个过程不仅受此类表面活性剂性质的影响,还受其他因素的影响,如添加剂的存在、制剂制备以及包封的疏水或亲水分子的性质。本综述旨在提供关于使用阳离子非离子型脂质体进行基因递送的最新信息,特别强调改善反义寡核苷酸(ASO)、小干扰RNA(siRNA)、适体和质粒(pDNA)的运输。